Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Archives of Toxicology|December 4, 2024
Does a carboxamide moiety alter the toxicokinetics of synthetic cannabinoids? A study after pulmonary and intravenous administration of cumyl-5F-P7AICA to pigsNadja Walle, Christiane Dings, Omar Zaher, et al.
Thrombosis and Haemostasis|February 8, 2013
Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal diseaseDmytro Khadzhynov, Frank Wagner, Stephan Formella, et al.
Journal of Hepatology|February 10, 2015
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approachSandra M Ehrlich, Johanna Liebl, Maximilian A Ardelt, et al.
Children (Basel, Switzerland)|December 23, 2023
Motivations for Adolescent COVID-19 Vaccination: A Comparative Study of Adolescent and Caregiver Perspectives in GermanyTobias Rothoeft, Folke Brinkmann, Christoph Maier, et al.
Antiviral Research|March 21, 2026
Positive net antiviral benefit of bexarotene against patient-derived archetype and rearranged BK polyomavirus isolatesPascal Feld, Lise Lauterbach-Rivière, Katharina Martha Götz, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2025
Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapyKatharina M Götz, Sascha Kreuer, Anke-Katrin Volz, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2023
Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictionsHelena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, et al.
Journal of Hepatology|May 2, 2016
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa studyPavel Bogomolov, Alexander Alexandrov, Natalia Voronkova, et al.
Molecular Cancer Therapeutics|December 10, 2020
Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining <i>In Vitro</i> Experiments with Systems ModelingArthur J Van De Vyver, Tina Weinzierl, Miro J Eigenmann, et al.
American Heart Journal|June 20, 2012
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)Frans Van de Werf, Martina Brueckmann, Stuart J Connolly, et al.
Pageof 13